Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Graham

Showing results (121-130 of 166) with videos related to

Pageof 17
Sort By:
American Journal of Public Health|October 23, 2024
Trends in Medical Encounters Involving Cannabis-Related Disorders Among US Medicare Beneficiaries, 2017-2022Silvia Perez-Vilar, Sara Kazemian, Christina Greene, et al.
Pharmacoepidemiology and Drug Safety|March 6, 2024
Comparing the Centers for Medicare and Medicaid Services (CMS) enrollment data death dates to the National Death Index (NDI)Dinci Pennap, Richard S Swain, Sandia Akhtar, et al.
Pharmacoepidemiology and Drug Safety|July 20, 2017
Antihypertensive drug associated angioedema: effect modification by race/ethnicityMarsha E Reichman, Michael Wernecke, David J Graham, et al.
Addiction (Abingdon, England)|January 31, 2016
A comparison of neuropsychiatric adverse events during early treatment with varenicline or a nicotine patchFrancesca E Cunningham, Kwan Hur, Diane Dong, et al.
JAMA|December 2, 2004
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugsDavid J Graham, Judy A Staffa, Deborah Shatin, et al.
Annals of Epidemiology|September 25, 2016
Challenges in evaluating cancer as a clinical outcome in postapproval studies of drug safetySimone P Pinheiro, Donna R Rivera, David J Graham, et al.
Endocrine|February 2, 2022
Rates of, and factors associated with, switching among generic levothyroxine preparations in commercially insured American adultsJuan P Brito, Yihong Deng, Joseph S Ross, et al.
Pain Medicine (Malden, Mass.)|May 16, 2014
Candidate metrics for evaluating the impact of prescriber education on the safe use of extended-release/long-acting (ER/LA) opioid analgesicsMary E Willy, David J Graham, Judith A Racoosin, et al.
Journal of Clinical Epidemiology|February 1, 2005
Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysisSusan E Andrade, David J Graham, Judy A Staffa, et al.
Diabetes Care|November 11, 2017
Prospective Postmarketing Surveillance of Acute Myocardial Infarction in New Users of Saxagliptin: A Population-Based StudySengwee Toh, Marsha E Reichman, David J Graham, et al.
Pageof 17

Showing results (121-130 of 166) with videos related to

Sort By:
Pageof 17
American Journal of Public Health|October 23, 2024
Trends in Medical Encounters Involving Cannabis-Related Disorders Among US Medicare Beneficiaries, 2017-2022Silvia Perez-Vilar, Sara Kazemian, Christina Greene, et al.
Pharmacoepidemiology and Drug Safety|March 6, 2024
Comparing the Centers for Medicare and Medicaid Services (CMS) enrollment data death dates to the National Death Index (NDI)Dinci Pennap, Richard S Swain, Sandia Akhtar, et al.
Pharmacoepidemiology and Drug Safety|July 20, 2017
Antihypertensive drug associated angioedema: effect modification by race/ethnicityMarsha E Reichman, Michael Wernecke, David J Graham, et al.
Addiction (Abingdon, England)|January 31, 2016
A comparison of neuropsychiatric adverse events during early treatment with varenicline or a nicotine patchFrancesca E Cunningham, Kwan Hur, Diane Dong, et al.
JAMA|December 2, 2004
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugsDavid J Graham, Judy A Staffa, Deborah Shatin, et al.
Annals of Epidemiology|September 25, 2016
Challenges in evaluating cancer as a clinical outcome in postapproval studies of drug safetySimone P Pinheiro, Donna R Rivera, David J Graham, et al.
Endocrine|February 2, 2022
Rates of, and factors associated with, switching among generic levothyroxine preparations in commercially insured American adultsJuan P Brito, Yihong Deng, Joseph S Ross, et al.
Pain Medicine (Malden, Mass.)|May 16, 2014
Candidate metrics for evaluating the impact of prescriber education on the safe use of extended-release/long-acting (ER/LA) opioid analgesicsMary E Willy, David J Graham, Judith A Racoosin, et al.
Journal of Clinical Epidemiology|February 1, 2005
Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysisSusan E Andrade, David J Graham, Judy A Staffa, et al.
Diabetes Care|November 11, 2017
Prospective Postmarketing Surveillance of Acute Myocardial Infarction in New Users of Saxagliptin: A Population-Based StudySengwee Toh, Marsha E Reichman, David J Graham, et al.
Pageof 17